Amgen stock tumbled late Tuesday on a report its high-profile weight-loss shot, MariTide, could be linked to bone mineral ...

Shares of Amgen fell as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss ...

Key Takeaways The S&P 500 slipped 0.3% on Tuesday, Nov. 12, the benchmark index's first negative trading day since last ...

Thomas also held leadership posts with Novartis, Bristol-Myers Squibb, Beigene, GSK and Amgen. Thomas received a bachelor's ...

Amgen (AMGN) stock falls as Cantor Fitzgerald raises safety concerns over bone mineral density loss linked to obesity ...

On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value.

Another BiTE in development by Amgen binds CD3 on T cells to STEAP1 on prostate cancer cells. In a preliminary clinical study ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

US endocrinologists are favoring antithyroid drugs over radioactive iodine in initial Graves’ disease treatment, and new ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

Biotechnology firm Amgen has been awarded menopause-friendly employer accreditation as part of its aim to ensure all of its ...